Literature DB >> 10690583

Etiology and pathophysiology of inflammatory bowel disease--environmental factors.

T Andus1, V Gross.   

Abstract

Environmental factors play an important role in the pathophysiology of inflammatory bowel disease. There is a strong and consistent association between smoking and Crohn's disease, and between nonsmoking and ulcerative colitis. Despite extensive research, the exact pathophysiological mechanisms for these associations remain unclear. In spite of this, some clinical trials with nicotine-patches showed beneficial effects for the treatment of ulcerative colitis. Associations of Crohn's disease and ulcerative colitis with other environmental factors are weaker like the association with use of oral contraceptives or those less well investigated such as the association with childhood hygiene. Most studies suggesting a potential pathogenetic role of Mycobacterium paratuberculosis or an effect of tuberculostatic therapy in Crohn's disease could not be reproduced by others. Perinatal or childhood infections by viruses like measles are heavily debated, but not proven to be causal for inflammatory bowel disease. Coagulation disorders have been described as protecting from inflammatory bowel disease, suggesting hypercoagulability to be a pathogenetic factor. Some studies described that appendectomy may prevent the onset of ulcerative colitis in man and mice. Other environmental factors such as hydrogen sulfide, tonsillectomy, diet, blood transfusions, and Listeria also require confirmation. There are, however, convincing data from genetic animal models and twin studies that environmental factors as the intestinal bacterial flora interact with susceptible hosts to cause inflammatory bowel disease. Inflammatory bowel diseases have multifactorial etiologies, which require a differentiated approach for treatment and prevention.

Entities:  

Mesh:

Year:  2000        PMID: 10690583

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  13 in total

Review 1.  Clinical aspects and pathophysiology of inflammatory bowel disease.

Authors:  Barbara A Hendrickson; Ranjana Gokhale; Judy H Cho
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

2.  Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved.

Authors:  Nadeem A Afzal; Sue Davies; Morine Paintin; Franck Arnaud-Battandier; John A Walker-Smith; Simon Murch; Robert Heuschkel; John Fell
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

3.  (E)-metanicotine hemigalactarate (TC-2403-12) inhibits IL-8 production in cells of the inflamed mucosa.

Authors:  Tanja Spoettl; Christine Paetzel; Hans Herfarth; Merouane Bencherif; Juergen Schoelmerich; Roland Greinwald; Gregory J Gatto; Gerhard Rogler
Journal:  Int J Colorectal Dis       Date:  2006-05-20       Impact factor: 2.571

4.  A meta-analysis of antibiotic therapy for active ulcerative colitis.

Authors:  Roja Rahimi; Shekoufeh Nikfar; Ali Rezaie; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2007-04-06       Impact factor: 3.199

5.  Gastrointestinal Tract Pathology in a BALB/c Niemann-Pick Disease Type C1 Null Mouse Model.

Authors:  Antony Cougnoux; Miyad Movassaghi; Jaqueline A Picache; James R Iben; Fatemeh Navid; Alexander Salman; Kyle Martin; Nicole Y Farhat; Celine Cluzeau; Wei-Chia Tseng; Kathryn Burkert; Caitlin Sojka; Christopher A Wassif; Niamh X Cawley; Richard Bonnet; Forbes D Porter
Journal:  Dig Dis Sci       Date:  2018-01-22       Impact factor: 3.199

6.  In vivo CpG DNA/toll-like receptor 9 interaction induces regulatory properties in CD4+CD62L+ T cells which prevent intestinal inflammation in the SCID transfer model of colitis.

Authors:  F Obermeier; U G Strauch; N Dunger; N Grunwald; H C Rath; H Herfarth; J Schölmerich; W Falk
Journal:  Gut       Date:  2005-05-05       Impact factor: 23.059

7.  Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats.

Authors:  T G Moreels; R J Nieuwendijk; J G De Man; B Y De Winter; A G Herman; E A Van Marck; P A Pelckmans
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

8.  Calcitriol analog ZK191784 ameliorates acute and chronic dextran sodium sulfate-induced colitis by modulation of intestinal dendritic cell numbers and phenotype.

Authors:  Ulrike G Strauch; Florian Obermeier; Nicole Grunwald; Nadja Dunger; Heiko C Rath; Jurgen Schölmerich; A Steinmeyer; U Zügel; H H Herfarth
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

Review 9.  Inflammatory bowel disease: review from the aspect of genetics.

Authors:  Shunji Ishihara; M M Aziz; Takafumi Yuki; Hideaki Kazumori; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2009       Impact factor: 7.527

10.  Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis.

Authors:  F Obermeier; N Dunger; U G Strauch; N Grunwald; H Herfarth; J Schölmerich; W Falk
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.